Zhejiang Provincial Key Laboratory of Biometrology and Inspection & Quarantine, College of Life Sciences, China Jiliang University, Hangzhou 310018, China.
Institute for Pharmaceutical Sciences, Pharmaceutical Biology and Biotechnology, University of Freiburg, 79104 Freiburg, Germany.
J Zhejiang Univ Sci B. 2018;19(9):708-717. doi: 10.1631/jzus.B1800046.
otrA resembles elongation factor G (EF-G) and is considered to be an oxytetracycline (OTC)-resistance determinant in Streptomyces rimosus. In order to determine whether otrA also conferred resistance to OTC and other aminoglycosides to Streptomyces coelicolor, the otrA gene from S. rimosus M527 was cloned under the control of the strong ermE promoter. The resulting plasmid, pIB139-otrA, was introduced into S. coelicolor M145 by intergeneric conjugation, yielding the recombinant strain S. coelicolor M145-OA. As expected S. coelicolor M145-OA exhibited higher resistance levels specifically to OTC and aminoglycosides gentamycin, hygromycin, streptomycin, and spectinomycin. However, unexpectedly, S. coelicolor M145-OA on solid medium showed an accelerated aerial mycelia formation, a precocious sporulation, and an enhanced actinorhodin (Act) production. Upon growth in 5-L fermentor, the amount of intra- and extracellular Act production was 6-fold and 2-fold higher, respectively, than that of the original strain. Consistently, reverse transcription polymerase chain reaction (RT-PCR) analysis revealed that the transcriptional level of pathway-specific regulatory gene actII-orf4 was significantly enhanced in S. coelicolor M145-OA compared with in S. coelicolor M145.
otrA 类似于延伸因子 G(EF-G),被认为是棘孢小单孢菌(Streptomyces rimosus)中强力霉素(OTC)耐药决定因子。为了确定otrA 是否也赋予棘孢小单孢菌对 OTC 和其他氨基糖苷类抗生素的耐药性,从棘孢小单孢菌 M527 中克隆了 otrA 基因,该基因受强 ermE 启动子的控制。所得质粒 pIB139-otrA 通过种间接合引入链霉菌 M145,得到重组菌株链霉菌 M145-OA。如预期的那样,链霉菌 M145-OA 对 OTC 和氨基糖苷类抗生素庆大霉素、潮霉素、链霉素和壮观霉素表现出更高的耐药水平。然而,出乎意料的是,链霉菌 M145-OA 在固体培养基上表现出加速的气生菌丝形成、早熟的孢子形成和增强的放线紫红素(Act)产生。在 5-L 发酵罐中生长时,胞内和胞外 Act 的产量分别比原始菌株高 6 倍和 2 倍。一致地,逆转录聚合酶链反应(RT-PCR)分析表明,与链霉菌 M145 相比,链霉菌 M145-OA 中途径特异性调节基因 actII-orf4 的转录水平显著增强。